Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marium Husain

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Journal of Geriatric Oncology|February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancerAndrew C Johns, Lai Wei, Madison Grogan, et al.
BMC Cancer|May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medicationsDaniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
Cancer Investigation|October 10, 2025
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint InhibitorsSandip H Patel, Songzhu Zhao, Mingjia Li, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsCaroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2026
Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signaturesAnnastasia Petouhoff, Ryan Hicks, Marium Husain, et al.
Cancer Research Communications|July 17, 2024
The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitorsCaroline E Dravillas, Samuel S Coleman, Rebecca Hoyd, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A bioinformatics tool for identifying intratumoral microbes from the ORIEN datasetCankun Wang, Anjun Ma, Megan E McNutt, et al.
Cancer Research Communications|June 21, 2024
The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal CancerMartin Benej, Rebecca Hoyd, McKenzie Kreamer, et al.
Cancer Research Communications|January 23, 2024
A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN DatasetCankun Wang, Anjun Ma, Yingjie Li, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|February 20, 2025
The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)Caroline Dravillas, Nyelia Williams, Marium Husain, et al.
Journal of Geriatric Oncology|February 25, 2021
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancerAndrew C Johns, Lai Wei, Madison Grogan, et al.
BMC Cancer|May 8, 2020
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medicationsDaniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, et al.
Cancer Investigation|October 10, 2025
Early Changes in Lymphocyte/Monocyte Ratio on Treatment as a Prognostic Marker to Predict Overall Survival in Patients with Advanced Cancer Treated with Immune Checkpoint InhibitorsSandip H Patel, Songzhu Zhao, Mingjia Li, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsCaroline E Wheeler, Samuel S Coleman, Rebecca Hoyd, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2026
Impact of proton pump inhibitors on immunotherapy is modulated by prior chemotherapy and linked to gut microbiome-immune cell signaturesAnnastasia Petouhoff, Ryan Hicks, Marium Husain, et al.
Cancer Research Communications|July 17, 2024
The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint InhibitorsCaroline E Dravillas, Samuel S Coleman, Rebecca Hoyd, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
A bioinformatics tool for identifying intratumoral microbes from the ORIEN datasetCankun Wang, Anjun Ma, Megan E McNutt, et al.
Cancer Research Communications|June 21, 2024
The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal CancerMartin Benej, Rebecca Hoyd, McKenzie Kreamer, et al.
Cancer Research Communications|January 23, 2024
A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN DatasetCankun Wang, Anjun Ma, Yingjie Li, et al.
Pageof 4